News

Korea Ginseng Corporation Unveils G1899 for Health Markets

Korea Ginseng Corporation Unveils G1899 for Health Markets

Korea Ginseng Corporation Launches G1899, a Premium Ingredient

Korea Ginseng Corporation (KGC) proudly announces the launch of its standardized ingredient brand, G1899, representing a stride into the global business-to-business (B2B) health ingredient market. This new brand highlights KGC's commitment to providing high-quality natural ingredients while showcasing the exceptional benefits of red ginseng.

G1899: A New Era for Health Ingredients

The name G1899 draws upon KGC's rich history, established in 1899, and signifies a forward-looking vision. The brand’s goal is to transcend traditional offerings of red ginseng, expanding into a comprehensive assortment of standardized, natural ingredients tailored for international distribution.

The Launch at SSG 2025

KGC debuted G1899 at SupplySide Global 2025 (SSG 2025), showcasing its commitment to the highest standards in ingredient quality. At this major international event, KGC highlighted the scientific integrity of red ginseng and demonstrated its extensive research backing.

Red Ginseng's Recognition

As global demand for natural, functional health ingredients surges, red ginseng emerges as a leader—acknowledged for its non-GMO, gluten-free properties. The Korean Ministry of Food and Drug Safety recognizes ginseng for seven key health functions, with over 1,200 scientific studies attesting to its efficacy.

Highlighting Quality Management Systems

KGC emphasizes stringent quality management systems that ensure each batch of ginseng meets rigorous standards. The company's contract cultivation with local farmers includes meticulous soil management, yielding high-purity ingredients.

Commitment to Safety and Quality

Each product batch lives up to KGC’s quality promise, undergoing more than 430 safety tests. International certifications such as HACCP and FSSC 22000 affirm KGC's commitment to excellence, making their Wonju Plant a pioneer in the health functional food sector.

Innovation through Research and Development

Central to KGC’s strategy is its R&D Center, aimed at pioneering advancements in health ingredients. The center spurs innovation, holding over 320 patents along with 350 academic publications focused on ginseng science.

Global Recognition for KGC

KGC received the esteemed Varro E. Tyler Award from the American Botanical Council (ABC) at Natural Products Expo West 2025, acknowledging its significant role in the global health market. Notably, KGC has retained the top market share for eleven consecutive years, positioning itself prominently in ginseng retail.

Engagement with Global Partners

At SSG 2025, KGC effectively engaged with global partners by showcasing multiple functional food applications, including liquids, powders, capsules, tablets, and gummies. This expansive display of products underlines KGC's dedication to versatility and innovation in functional health.

G1899: The Future of Health Ingredients

Looking ahead, KGC is excited to foster relationships with partners across the ingredient and finished-product landscape. With G1899 as a cornerstone, KGC aims to deliver premium health solutions that resonate with the modern consumer's wellness aspirations.

Frequently Asked Questions

What is G1899?

G1899 is a new standardized ingredient brand launched by KGC, representing a blend of rich heritage and innovative health solutions.

What are the benefits of red ginseng?

Red ginseng is recognized for its numerous health benefits, including its natural, non-GMO ingredients and its gluten-free properties.

Where was G1899 launched?

G1899 was officially unveiled at SupplySide Global 2025, a major B2B health ingredient exhibition.

How does KGC ensure quality?

KGC maintains high-quality standards through contract cultivation, rigorous testing, and compliance with international certifications.

What innovations does KGC focus on?

KGC's R&D Center focuses on ingredient development from formulation to research, striving for groundbreaking advancements in health ingredients.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Aberdeen's Reverse Split: What Investors Need to Know

Updated Category News Views 31

Tackling Aberdeen's New Playbook Aberdeen Multi-Market Income Fund (NYSE: MMT) is pulling the trigger on a 1-for-4 reverse stock split come November 9, 2026. This isn't your average headline-grabbing move but one that could shake up how MMT trades. It’s a classic case of tidying up shop, aiming to bolster the share price and streamline share trading. No Change in Fund...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 128

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
Abbott's Oncodetect Test: Game-Changer for Cancer Recurrence

Updated Category News Views 4

Pioneering Progress in Colorectal Cancer Detection There's a new player in the world of cancer diagnostics, and it's setting a fresh standard. Abbott's Oncodetect test, featured at the ESMO Congress, has shown a profound leap in sensitivity—30 percent over the older whole-exome sequencing approach. For those doing the math on the stock charts, Abbott (NYSE: ABT) is...

Continue Reading
Hansa's Idefirix Shows Promise for Kidney Transplants

Updated Category News Views 22

Compelling Progress from Hansa Biopharma Y'know, navigating through the biotech jungle isn't for the faint-hearted. Hansa Biopharma's recent results with Idefirix could just be the beacon of hope for patients struggling on transplant lists. Announced at the ASN Kidney Week—a name that's got weight, by the way—these findings aren't just filling space. They're promising...

Continue Reading
Unicoin’s 'RISE IN PINK' Blends Crypto and Charity

Updated Category News Views 24

The New Face of Charitable Giving: Crypto and Cause Turning the spotlight on how blockchain and altruism can mesh, Unicoin's latest campaign isn’t just your average philanthropic endeavor. With 'RISE IN PINK', they're out to change the game, blending digital assets with a deep human cause—breast cancer awareness and support. Technology Meets Human Cause Imagine...

Continue Reading
Bimbo Bakeries Teamsters Avert Strike in Chicago

Updated Category News Views 48

Teamsters Flex Muscle in Bakery Dispute Sometimes, it's a matter of holding your ground until the last minute. That’s exactly the brand of guts the workers at Bimbo Bakeries in Chicago just displayed, securing a robust agreement mere hours before hitting the picket line. These 275 warehouse and route sales folks threw down the gauntlet with management and,...

Continue Reading
Medline's MedTrans Rodeo: Honoring Driver Excellence

Updated Category News Views 52

Rollin' Down the Road of Excellence In the world of healthcare logistics, Medline's MedTrans team isn't just steering trucks—they're steering safety culture and supply chain efficiency. This October, they wrapped up their fourth annual National Truck Rodeo in Mundelein, Illinois. And let me tell you, it was more than just a fancy event. It was about celebrating the real...

Continue Reading
Concrete Admixtures Market: A Billion-Dollar Boom

Updated Category News Views 24

A Look Under the Hood of Concrete Admixtures It's a concrete jungle out there, folks—literally. The once overlooked market of concrete admixtures is gearing up for quite the makeover, projected to hit USD 35.87 billion by 2035. For those of you tuning in, we're talking about chemicals that mix into your average concrete to change its properties. And, believe it or not,...

Continue Reading
Dimora Medical Boosts Advanced Wound Care at HS Conference

Updated Category News Views 74

Empowering the HS Community with Innovations Look, if you’ve walked a mile in someone else's shoes—particularly ones dealing with hidradenitis suppurativa (HS)—you’d know what a relentless grind managing those exuding wounds can be. Dimora Medical, known for navigating the tricky territory of wound care, threw its hat into the ring at the HS Connect Empower...

Continue Reading
Bay Area to Host New Jerry Garcia Arts Center

Updated Category News Views 43

Celebrating a Legend in the Heart of San Francisco The Bay Area is set to become home to a vibrant new center dedicated to celebrating the multifaceted legacy of Jerry Garcia, Grateful Dead co-founder. Announced by the Garcia family, with the help of archival platform Starchive and project coordinator Christopher McCutcheon, the Jerry Garcia Music Arts Center promises to...

Continue Reading

Top 5 Most Recently Viewed Articles

Legal Investigation: Crocs Investors Urged to Act Now

Updated Category News Views 109

Investors Encouraged to Take Action Regarding Crocs Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson encourages investors who suffered losses exceeding $100,000 in Crocs to contact him directly to discuss their options. If you have experienced losses of over $100,000 related to Crocs during recent financial periods, calling Faruqi & Faruqi might...

Continue Reading
Exploring the Impact of .lunar Domains on Space Ventures

Updated Category News Views 120

Unveiling the .lunar Domain Extension Unstoppable Domains and Copernic Space have made waves with their groundbreaking initiative involving the launch of the .lunar domain extension. This innovative top-level domain is designed specifically for trailblazers exploring the realms of space, cryptocurrencies, and decentralized physical infrastructure networks (DePIN). By...

Continue Reading
Investigation Launched for Investors in Dave Inc. - DAVE

Updated Category News Views 297

Investigation Overview for Dave Inc. Investors Pomerantz LLP is currently conducting an investigation aimed at protecting the interests of investors in Dave Inc. (NASDAQ: DAVE). Investors concerned about the validity of their investments or those seeking to understand more about potential corporate misconduct are encouraged to reach out. Key Allegations Against Dave Inc....

Continue Reading
Innovative Solutions Unveiled at Safety Pharmacology Society Meeting

Updated Category News Views 51

Exciting Innovations from Harvard Bioscience Harvard Bioscience, Inc. (NASDAQ: HBIO) is gearing up to present a variety of groundbreaking products at an important annual gathering tailored for safety pharmacologists. The company is dedicated to advancing life sciences and has crafted solutions that meet the varied needs of researchers and developers in the pharmaceutical...

Continue Reading
Upcoming Earnings Report for Cinemark Holdings Inc.

Updated Category News Views 138

Key Insights Ahead of Cinemark's Earnings Release Cinemark Hldgs (CNK) is gearing up to unveil their quarterly earnings report. Investors are buzzing with anticipation, keen to see how the company measures up against analyst expectations. Analysts are predicting an earnings per share (EPS) of $0.76, a number that reflects optimistic sentiment surrounding the company's...

Continue Reading